Preferences
Related Series
Related Segments


Asia/Oceania PACS 2025
Dynamic Solutions & Strategic Partnerships Drive Customer Success
The PACS market in Asia and Oceania is evolving; healthcare organizations are looking for technology that is more robust, especially in Asia, where organizations are wanting to solidify or scale their enterprise imaging strategies. Furthermore, organizations want to work with vendors who can be long-term strategic partners in helping optimize the product. This report—KLAS’ first to share PACS performance data from Asia and Oceania individually—examines satisfaction from customers across 13 countries, specifically looking at relationships, support, breadth of functionality, and each vendor’s ability to meet expectations around product innovation and upgrades.
If you don't have a login, getting started is easy.
Key Findings:
- In Asia, Medsynaptic Is Top Rated by Both High- & Low-Volume Organizations; In Oceania, Sectra Has Highest Performance & Offers Reliable Solution
- Multiple GE HealthCare & Intelerad Respondents Dissatisfied with Product & Consequently Plan to Replace
- Medsynaptic Stands Out by Building Trusted Support Relationships; Fujifilm & INFINITT Offer Solid Product Across Several Different Countries
- Cost & Pace of Innovation Are Challenges for GE HealthCare & Philips Respondents
- Sectra Customers Most Satisfied Thanks to Product Reliability & Ease of Use; AGFA Customers Report Improved Experience Since Lengthy Transition from IMPAX
- Intelerad Customers Frustrated with Stagnant Product, Delayed Support & Frequent Charges

Writer
Sarah Brown

Designer
Breanne Hunter

Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.